This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a high IFN score being associated with an increased risk for clinical worsening.
Medscape Medical News